We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$175M
2
WELL icon
Welltower
WELL
+$148M
3
CUZ icon
Cousins Properties
CUZ
+$121M
4
DLR icon
Digital Realty Trust
DLR
+$103M
5
VICI icon
VICI Properties
VICI
+$96.6M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
1126
DELISTED
Amicus Therapeutics
FOLD
$9K ﹤0.01%
913
+423
+86% +$4.33K
MYGN icon
1127
Myriad Genetics
MYGN
$502M
$9K ﹤0.01%
267
+126
+89% +$4.18K
PCRX icon
1128
Pacira BioSciences
PCRX
$1.05B
$9K ﹤0.01%
152
+70
+85% +$4.03K
PTCT icon
1129
PTC Therapeutics
PTCT
$6.25B
$9K ﹤0.01%
242
+103
+74% +$4.23K
QNCX icon
1130
Quince Therapeutics
QNCX
$18.9M
$9K ﹤0.01%
+1
New +$15.9K
SAGE
1131
DELISTED
Sage Therapeutics
SAGE
$9K ﹤0.01%
201
+85
+73% +$3.9K
GEN icon
1132
PUT
Gen Digital
GEN
$16.6B
$8K ﹤0.01%
2,104
+104
+5% +$2.71K
LGND icon
1133
Ligand Pharmaceuticals
LGND
$5.94B
$8K ﹤0.01%
91
+38
+72% +$2.94K
AMRN
1134
Amarin Corp
AMRN
$293M
$7K ﹤0.01%
67
+31
+86% +$3.05K
GMAB icon
1135
Genmab
GMAB
$17.8B
$7K ﹤0.01%
165
+79
+92% +$3.55K
IRWD icon
1136
Ironwood Pharmaceuticals
IRWD
$626M
$7K ﹤0.01%
558
+257
+85% +$3.32K
RCKT icon
1137
Rocket Pharmaceuticals
RCKT
$343M
$7K ﹤0.01%
218
+98
+82% +$3.57K
RVMD icon
1138
Revolution Medicines
RVMD
$39.1B
$7K ﹤0.01%
252
+109
+76% +$3.17K
XNCR icon
1139
Xencor
XNCR
$1.48B
$7K ﹤0.01%
200
+92
+85% +$3.02K
RVNC
1140
DELISTED
Revance Therapeutics, Inc.
RVNC
$7K ﹤0.01%
246
+105
+74% +$3K
DCPH
1141
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$7K ﹤0.01%
199
+92
+86% +$2.94K
NSTG
1142
DELISTED
NanoString Technologies, Inc.
NSTG
$7K ﹤0.01%
156
+73
+88% +$4.2K
ALEC icon
1143
Alector
ALEC
$169M
$6K ﹤0.01%
277
+128
+86% +$3.58K
CSTL icon
1144
Castle Biosciences
CSTL
$725M
$6K ﹤0.01%
86
+38
+79% +$2.67K
GRFS
1145
Grifois
GRFS
$5.44B
$6K ﹤0.01%
398
+174
+78% +$2.63K
IGMS
1146
DELISTED
IGM Biosciences
IGMS
$6K ﹤0.01%
88
+42
+91% +$3.21K
LEGN icon
1147
Legend Biotech
LEGN
$3.68B
$6K ﹤0.01%
109
+69
+173% +$2.87K
RGNX icon
1148
Regenxbio
RGNX
$615M
$6K ﹤0.01%
146
+62
+74% +$2.23K
KLRS
1149
Kalaris Therapeutics
KLRS
$79.5M
$6K ﹤0.01%
10
+5
+100% +$2.32K
NGM
1150
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6K ﹤0.01%
265
+119
+82% +$2.62K
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.